A 3-day-old full-term Indian neonatal male infant presents with clinical jaundice. Serum bilirubin is 14 mg/dL. Phototherapy is initiated. On day 5, despite 24 hours of continuous phototherapy, the bilirubin level is 18 mg/dL and rising. What is the drug of choice for this case?

Explanation

## Clinical Context This neonate has **severe hyperbilirubinemia unresponsive to phototherapy** — a medical emergency requiring adjunctive pharmacotherapy to prevent bilirubin encephalopathy (kernicterus). ## Why IVIG is First-Line **Key Point:** Intravenous immunoglobulin (IVIG) is the **gold-standard adjunctive drug** for severe neonatal hyperbilirubinemia unresponsive to phototherapy, particularly in **hemolytic disease** (Rh incompatibility, ABO incompatibility, G6PD deficiency). **Mechanism:** 1. IVIG blocks Fc receptors on fetal macrophages in the reticuloendothelial system 2. Prevents hemolysis and destruction of sensitized RBCs 3. Reduces the rate of bilirubin production 4. Effective dose: **0.5–1 g/kg IV over 2–4 hours** **Clinical Pearl:** IVIG can reduce the need for exchange transfusion by up to 50% when given early (within first 24–48 hours of phototherapy failure). **High-Yield:** IVIG is indicated when: - Bilirubin is rising despite adequate phototherapy - Hemolytic disease is suspected or confirmed - Risk of kernicterus is high ## Comparison with Other Options | Agent | Role | Timing | Effectiveness | |-------|------|--------|----------------| | **IVIG** | Adjunct to phototherapy | Early (first 24–48 hrs) | Reduces hemolysis; 50% reduction in exchange transfusion need | | **Phenobarbital** | Enzyme inducer (obsolete) | Days 1–3 (preventive) | Minimal effect in acute severe hyperbilirubinemia; rarely used now | | **Metalloporphyrin** | Heme oxygenase inhibitor | Experimental/research | Not approved for routine clinical use in neonates | | **Ursodeoxycholic acid** | Cholestasis agent | Chronic neonatal cholestasis | No role in hemolytic hyperbilirubinemia | **Warning:** Do NOT delay exchange transfusion while waiting for IVIG to work if bilirubin exceeds exchange transfusion threshold — IVIG is an adjunct, not a replacement. ## Treatment Algorithm for Severe Hyperbilirubinemia ```mermaid flowchart TD A["Severe neonatal hyperbilirubinemia<br/>(bilirubin rising despite phototherapy)"]:::outcome --> B{"Hemolytic disease<br/>suspected?"}:::decision B -->|"Yes or likely"| C["Start IVIG 0.5-1 g/kg IV"]:::action B -->|"No hemolysis"| D["Optimize phototherapy<br/>Consider exchange transfusion threshold"]:::action C --> E{"Bilirubin response<br/>in 6-12 hrs?"}:::decision E -->|"Yes, declining"| F["Continue phototherapy<br/>Monitor closely"]:::action E -->|"No, still rising"| G["Prepare for exchange transfusion"]:::urgent D --> H{"Bilirubin at/above<br/>exchange threshold?"}:::decision H -->|"Yes"| G H -->|"No"| I["Intensive phototherapy"]:::action ``` [cite:Nelson Textbook of Pediatrics 21e Ch 102]